EMMECELL

Emmetrope Ophthalmics LLC, (aka "Emmecell") is a privately held, clinical-stage biotechnology company pioneering the discovery and development of cell-based therapies for the treatment of eye diseases via its exclusive Magnetic Cell Delivery (MCD) nanoparticle platform technology... Our mission is to bring innovative regenerative medicine out of the laboratory and into patient care... CellMP is a subsidiary of Emmecell, and provides research, current good manufacturing practices (cGMP) manufacturing, and testing services to biotechnology startups.

Primary location: Menlo Park United States